Clinical Trials
9 trialsNCT05948943 2026-05-12
EPIK-L1
Novartis
Phase 2/3 Recruiting
NCT05983159 2026-05-05
TARGET-VM
Murdoch Childrens Research Institute
Phase 2 Recruiting
NCT06239480 2026-03-27
SELVA
Palvella Therapeutics, Inc.
Phase 3 Active not recruiting
NCT07477548 2026-03-17
A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies
Yonsei University
Phase 2 Not yet recruiting
NCT00975819 2026-01-06
Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
Boston Children's Hospital
Phase 2 Completed
NCT06892964 2025-03-25
IReg-LM
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase NA Recruiting
NCT05050149 2025-01-17
Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations
Palvella Therapeutics, Inc.
Phase 2 Completed
NCT01290484 2015-06-19
A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations
Stanford University
Phase 1/2 Completed
NCT00010452 2015-03-25
Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations
FDA Office of Orphan Products Development
Phase 2/3 Completed